Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1997-11-10
2000-10-10
Duffy, Patricia A.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
435 792, 436 63, 436811, G01N 3353
Patent
active
061300489
ABSTRACT:
Disclosed is a method of diagnosing Alzheimer's disease in a patient by measuring the level of a lysosomal hydrolase or lysosomal protease inhibitor in the patient's cerebrospinal fluid. The invention also features methods of measuring the progression of the disease and screening therapeutic compositions for treating Alzheimer's disease.
REFERENCES:
patent: 5387742 (1995-02-01), Cordell
Hultberg et al., "Diagnostic value of determinations of lysosomal in CSF of patients with neurological disease," Acta neurologica Scandinavia 57:201-215 (1978).
Li et al., "Abnormal distribution in cathepsin proteases and endogenous inhibitors (cystatins) in the hippocampus of patients with Alzheimer's disease, parkinsonism-dementia complex on Guam, and senile dementia and in the aged," Pathological Anatomy and Histopathology 423:185-194 (1993).
Aoyagi et al., "Enzymatic Changes in Cerebrospinal Fluid of Patients with Alzheimer-Type Dementia," J. Clin. Biochem Nutr., 14:133-139, (1993).
Appleyard et al., "Cholinesterase Activities in Cerebrospinal Fluid of Patients with Senile Dementia of Alzheimer Type," Brain 110:1309-1322 (1987).
Bernstein et al., "Lysosomal Proteinases as Putative Diagnostic Tools in Human Neuropathology: Alzheimer Disease (AD) and Schizophrenia," Acta Histochemica Suppl. Band ILII, S. 1924 (1992).
Burke et al., "Pathology of Epinephrine Neurons in Alzheimer," (Abstract) Soc. Neurosci Abstr 18:557 (1992).
Burke et al., "Increased Cathespin d Immunoreactivity in Inferior Olivary Neurons in Alzheimer's Disease," (abstract) Neurobiol Aging (Abstract No. 233) 15(S1:s57 (1994).
Cataldo et al., "Abnormal Lysosomal Hydrolase mRNA Expression in Neurons from Alzheimer Disease Brain," (Abstract) Soc. Neurosci. Abstr (Abstract No. 510.18) 20:1254 (1994).
Cataldo et al., "Abnormal Localization of Lysosomal Hydrolases in Diffuse Plaques of Alzheimer and Down Syndrome Brains," (Abstract) Neurobiol Aging (Abstract No. 472) 15(S1):S115 (1994).
Cataldo et al., "Enzymatically Active Lysosomal Protease are Associated with Amyloid Deposits in Alzheimer Brain," Proc. Natl. Acad. Sci USA 87:3861-3865 (1990).
Cataldo et al., "Increased Detection of Lysosmal Proteinase Antigens Associated with the Neuropathology of Alzheimer's Disease," Aging and Dementia: Plaques, Tangler, Amyloid 916.5 (Abstract).
Cataldo et al., "Lysosomal Abnormalities in Degenerating Neurons Link Neuronal Compromise to Senile Plaque Development in Alzheimer Disease," Brain Research 640:68-80 (1994).
Cataldo et al., "Lysosomal Proteinase Antigens are Prominently Localized within Senile Plaques of Alzheimer's Disease: Evidence for a Neuronal Origin," Brain Research 513:181-192 (1990).
Cataldo et al., Lysosomal Hydrolases of Different Classes are Abnormally Distributed in Brains of Patients with Alzheimer Disease, Proc. Natl. Acad. Sci. USA 88:10998-11002 (1991).
Cataldo et al., "Lysosomal Abnormalties are markers of Progressive Neuronal Dysfunction in Alzheimer Brain," (Abstract) Soc. Neurosci Abstr. (Abstract No. 81.14) 19:194 (1993).
Cataldo et al., "Lysosomal Hydrolases Colocalize with .beta.-Amyloid in Diffuse Plaques in Alzheimer Brain," (Abstract) Soc. Neurosci. Abstr. (Abstract No. 81.14) 19:194 (1993).
Cuzner et al., "Proteolytic Enzyme Activity of Blood Leukocytes and Cerebrospinal Fluid in Multiple Sclerosis," Ann. Neurol. 4:337-344 (1979).
Diedrich et al., "Neuropathological Changes in Scrapie and Alzheimer's Disease are Associated with Increased Expression of Apolipoprotein E and Cathepsin D in Astrocytes," J. Virology 65:4759-4768 (1991).
Golde et al., "Processing of the Amyloid Protein Precursor to Potentially Amloidongenic Derivatives," Science 225:729-730 (1991).
Hass et al., "Beta-Amyloid Peptide Land a 3kDa Fragment are Derived by Distant Cellular Mechanisms," J. Biol. Chem. 268:3021-3024 (1993).
Kirschke and Barrett, "Lysosomes: Their Role in Protein Breakdown," Academic Press 193-238 (1987).
Kitaguchi et al., "Determination of Amyloid .beta. Protein Precursors Harboring Active Form of Proteinase Inhibitor Domains in Cerebrospinal Fluid of Alzheimer's Disease Patients by Tryspin-Antibody Sandwich Elisa," Biochemical and Biophysical Research Communications 166(3):1453-1459 (1990).
Matus et al., "Age-Related Increase in a Cathepsin D Like Protease That Degrades Brain Microtubule-Associated Proteins," Amer. Chem Soc. 26:8083-8086 (1987).
McKhann et al., "Clinical Diagnosis of Alzheimer's Disease: Report of the NINCDS-ADRA Work Group Under the Auspices of Department of Health and Human Services Task Force on . . . ," Neurology 34:939-944 (1984).
Mirra et al., "The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)," Neurology 41:479-486 (1991).
Nakamura et al., "Abnormal Distribution of Cathepsins in th eBrain of Patients with Alzheimer's Disease," Neuroscience Letters 130:195-198 (1991).
Nakamura et al., Lysosome Instability in Aged Rat Brain, Neuroscience Letters 97:215-220 (1989).
Nixon et al., "Degradationof Neurofilament Proteins by Purified Human Brain Cathepsin D," J. Neurochemistry 43:507-516 (1984).
Nixon et al. "The Lysosomal System in Neuronal Cell death: A Review," Acad Sci 679:87-109 (1993).
Nixon et al., "The Lysosomal System in Neurons," Annals of the New York Academy of Sciences 674:65-68 (1992).
Nixon et al., "Endosomal-Lysosomal System Abnormalities: An Early Marker of Neuronal Dysfunction in Alzheimer Disease," Neurobiol. Aging 15:(S1):S32 (Abstract No. 133) (1994).
Nixon et al., "Endosomal-Lysosomal System Abnormalities in Alzheimer's Disease: Relationship to Neuronal Dysfunction and Amyloidosis," XIIth Int. Congress Neuropathology (Abstract) (1994).
Nixon et al., "Endosomal-Lysosomal System Abnormalaties: Relationship to Neuronal Dysfunction and Amyloidosis in Alzheimer's Disease," Trans. Am. Soc. Neurochem. (Abstract No. 120) 25:157 (1994).
Nixon et al., "Free Radicals, Proteolysis and the Degeneration of Neurons in Alzheimer Disease: How is the .beta.-Amyloid Link?," Neurobiol. Aging 15:463-469 (1994).
Nixon et al., "Increased Neuronal Cathepsin D Gene Expression and Active Release of Competent Protease in Alzheimer Disease," (Abstract No. 612.2) Soc. Neurosci. Abstr. 20:1484 (1994).
Nixon et al., "Lysosomal Proteolysis in Alzheimer Brain: Possible Roles in Neuronal Cell Death and Amyloid Formation," Elsevier Press 133-46 (1991).
Omar et al., "Acid Phosphatase Activity in Senile Plaques and Cerebralspinal Fluid of Patients with Alzheimer's Disease," Atch Pathol Lab Med 117:166-169 (1993).
Palmert et al., "Antisera to an Amino-Terminal Peptide Detect the Amyloid Protein Precursor of Alzheimer's Disease and Recognize Senile Plaques," Academic Press, Inc. 156(1):432-437 (1988).
Perry et al., "Amyloid Precursor Protein in Senile Plaques of Alzheimer Disease," The Lancet Sep. 24, 1988.
Riekkinen et al., "Proteinase in Human Cerebrospinal Fluid," J. Neurological Sciences, 7:97-106 (1968).
Ryan et al., "Pro-IL-1B Processed to its Mature Form by the Cysteine Proteinase Cathepsin B: A Potential Therapeutic Target in Alzheimer Disease," Soc. for Neurosci. Abstracts 18:97-2 (1992).
Schwagerl et al., "Elevated Levels of Cathepsin D in Cerebrospinal Fluid from Alzheimer Disease Patients," 4.sup.th Intl. Conf on Alz Dis and Related Dis. McLean Hospital, Harvard Univ. (1994).
Selkoe et al., ".beta.-Amyloid precursor protein of Alzheimer disease occurs as 110-to 135-kilodalton membrane-associated proteins in neural and nonneural tissues," Proc. Natl. Acad. Sci. 85:7341-7345 (1988).
Shoji et al., "Production of the Alzheimer amyloid .beta. Protein by Normal Proteolytic Processing," Science 258:126-130 (1992).
Schwagerl et al., Neurobiology of Aging, 15 Supplement 1, S115, received in Library on Jul. 7, 1994.
Takeda et al., "Change of Cathespin D Activities in Vinglastine-Injected Rabbit Brain and Alzheimer's Disease Brain," Neurochemical Research 11L:117-119 (1986).
Takeuchi et al., "Immunoassay and Activity of Calcium-Activated Neutral Proteinase (mCANP):Distribution in Soluble and Membrane-Associated Fractions in Human and . . . ," Neurochemistry 58:1526-1532 (1992).
Villanova et al., "Ri
Bieker-Brady Kristina
Duffy Patricia A.
McLean Hospital Corporation
LandOfFree
Method of diagnosing Alzheimer's disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of diagnosing Alzheimer's disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of diagnosing Alzheimer's disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2255242